Engineers Gate Manager »

Gain Therapeutics shares owned by Engineers Gate Manager

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Engineers Gate Manager from 13F filings

Historical chart of Engineers Gate Manager investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by Engineers Gate Manager consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by Engineers Gate Manager

Quarter filed Position value Share count Share price at filing
2025-12-31 $47k 15k 3.22

More positions owned by Engineers Gate Manager

Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invitation Homes (INVH)
Sabra Health Care REIT (SBRA)
Agree Realty Corporation (ADC)
First Industrial Realty Trust (FR)
Phillips Edison & Co Common Stock (PECO)
Acadia Rlty Tr Com Sh Ben Int (AKR)
Itt (ITT)
Independence Realty Trust In (IRT)
SYSCO Corporation (SYY)
Procter & Gamble Company (PG)
Boston Scientific Corporation (BSX)
Equinix (EQIX)
Mccormick & Co Com Non Vtg (MKC)

View all positions for Engineers Gate Manager

Top funds holding Gain Therapeutics

Marshall Wace
Potomac Capital Management
Susquehanna International
Jones Financial Companies, L.L
Vanguard Group
Cambridge Investment Research Advisors
DME Capital Management
Geode Capital Management
Citadel Advisors
Jane Street
BlackRock
Cresset Asset Management
State Street Corporation
LPL Financial
Northern Trust

View all funds holding Gain Therapeutics